Research advances in chimeric antigen receptor-modified T-cell therapy (Review)

Chimeric antigen receptor (CAR)-modified T-cells are T-cells that have been genetically engineered to express CAR molecules to target specific surface antigens on tumor cells. CAR T-cell therapy, a novel cancer immunotherapy, has been attracting increasing attention, since it exhibited notable effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yuxi, Song, Guiqin, Liang, Shichu, Li, Feifei, Liu, Kang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005741/
https://www.ncbi.nlm.nih.gov/pubmed/33790993
http://dx.doi.org/10.3892/etm.2021.9915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005741/
https://www.ncbi.nlm.nih.gov/pubmed/33790993
http://dx.doi.org/10.3892/etm.2021.9915

Ejemplares similares